Filter This View

  • December 1, 2011 | New York Law Journal

    New Deals

    Skadden, Sullivan & Cromwell Handle $11 Billion Pharmaceutical Deal Biopharmaceutical company Gilead Sciences will pay $11 billion to acquire drug d

    1 minute read

  • August 11, 2004 | National Law Journal

    The Surging Evolution of E-Discovery

    It can buckle the knees of the mightiest opponents, can end up costing millions to deal with, and can frustrate a case into premature settlement. Electronic discovery -- or e-discovery

    1 minute read

  • July 25, 2011 | Texas Lawyer

    2011 Lobbying Scorecard

    table cols="3" rows="70" heads="0" feet="0" xmlns:debug="urn:debug" xmlns:map="urn:mapping" xmlns:k4="http://www.vjoon.com/K4Export/1.4.2" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:xs="

    1 minute read

  • April 9, 2001 | Law.com

    The Importance of Information: Biotech Patents

    The following discussion thread excerpt is from an ongoing law.com online seminar, "The Life Science Revolution and the Law: Emerging Controversies in Biotechnology," produced in conjunc

    1 minute read

  • February 24, 2003 |

    Superior Court Limits Frye Test To 'Novel' Scientific Evidence

    The majority of an en banc Superior Court panel has issued an opinion that attempts to update case law regarding the admissibility of scientific evidence and reinstates a $5 million verdic

    1 minute read

  • August 30, 2011 | The Recorder

    Forecasting Forthcoming 'Biosimilar' Drug Regulations

    Traditional pharmaceuticals (small molecule drugs) have long been subject to widespread generic competition under the generic competition provisions of the Drug Price Competition and Patent Term Re

    1 minute read

  • Eisai Co. Ltd. v. Dr. Reddy's Laboratories, Ltd.

    Publication Date: 2008-07-23
    Practice Area:
    Industry:
    Date Filed: 2008-07-21
    Court: Fed. Cir.
    Judge: Rader, Circuit Judge.
    Attorneys: For plaintiff: For plaintiffs-appellees: Joseph O'Malley Jr., Paul, Hastings, Janofsky & Walker, New York. For defendants-appellants Dr. Reddy's Laboratories Ltd., et al.: Maurice Ross, Bud Larner, Short Hills, N.J.
    for defendant: For defendant-appellant Teva Pharmaceuticals USA Inc.: Henry Dinger, Goodwin Procter, Boston.
    Case Number: Nos. 2007-1397, -1398

    Published opinionBefore RADER, LINN, and PROST, Circuit Judges.On summary judgment, the United States District Court for the Southern District of New York found in favor of plaintiffs Eisai Co.,

  • Estate of Stacey A. Emiro

    Publication Date: 2004-08-27
    Practice Area:
    Industry:
    Court: Other
    Judge:
    Attorneys: For plaintiff:
    for defendant:
    Case Number:

    Surrogate's Court Surrogate Scarpino In this miscellaneous proceeding to compromise certain causes of action emanating from decedent's death, decedent's mother and administrat

  • December 31, 2009 | Daily Business Review

    Lobbyists earn healthy fees from bill

    President Obama may have shunned lobbyists, but he gave them a big gift with his health-care plan. From the moment he proposed overhauling the health-care system in February, the industry tu

    1 minute read

  • T., L. v TEVA PHARMACEUTICALS USA, INC.

    Publication Date: 2010-03-19
    Practice Area:
    Industry:
    Court: Appellate Division, 4th Dept
    Judge:
    Attorneys: For plaintiff:
    for defendant:
    Case Number: 83

    SUPREME COURT OF THE STATE OF NEW YORK Appellate Division, Fourth Judicial Department 83 CA 09-01800 PRESENT: SMITH, J.P., CENTRA, FAHEY,